Sanofi, GSK variant-specific COVID-19 shot found effective against Omicron - CNA

PARIS/LONDON: Late-stage data on an experimental COVID-19 vaccine from Sanofi and GSK has showed the shot confers protection against the Omicron variant of the virus, the companies said on Friday (Jun 24). The so-called bivalent vaccine targets the Beta varia…

PARIS/LONDON: Late-stage data on an experimental COVID-19 vaccine from Sanofi and GSK has showed the shot confers protection against the Omicron variant of the virus, the companies said on Friday (Ju… [+1922 chars]

full article...